{
  "id": "cluster_15_doc2",
  "content": "Patient 44938-Z, born 04/12/2008, completed stage 2 of dual-phase immunotherapy at Fair Oaks Allergy Center. Treatment plan includes biweekly sublingual doses (15.8 mcg egg white protein) paired with monthly oral challenges. Progress tracking shows 64% reduction in skin prick test reactivity since intervention began. Care team recommends continuing protocol through 2024, with neurology consult scheduled for potential migraine comorbidity.",
  "metadata": {
    "format": "medical_record"
  }
}